The University of Tokyo Edge Capital is a venture capital and private equity firm investing in early-stage technology companies associated with The University of Tokyo that is headquartered in Tokyo, Japan and was founded in 2004. The firms offers to help companies right from the decision to start a company up until initial publics offerings (IPOs) and merger & acquisitions.
The University of Tokyo Edge Capital typically acts as the lead investor using their ventures capital investment funds. The firm focuses on investing in life science, healthcare, physical sciences, engineering, and information technology companies. Notable investments made by The University of Tokyo Edge Capital include: Algal Bio, BitBiome, Brain Innovation, Elixirgen, Epigeneron, PepitDream, Tella, Naked Technologies, Popln, Prometech Software, Morpho, Liquid, Neural Pocket, BionicM, Exergy Power Systems, Microwave Chemical Co., Routrek Networks, GLM Co, Blume Ventures, and Deep30 Limited Partnership.